Category

All

Image of liver in yellow

FibroScan vs. Ultrasound Elastography

By All, Blog

A race is under way among pharmaceutical companies to develop drugs that treat a spectrum of liver diseases, including nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and its more severe form, nonalcoholic steatohepatitis (NASH).

Read More
FibroScan Mini+ 430 with display on

Noninvasive Exams Can Help Head Off Liver Disease

By All, Blog

A race is under way among pharmaceutical companies to develop drugs that treat a spectrum of liver diseases, including nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and its more severe form, nonalcoholic steatohepatitis (NASH).

Read More
Back and front views of FibroScan Mini+ 430

VA Tackles Liver Disease

By All, Blog

After reaching the goal of 100,000 veterans cured of hepatitis C virus (HCV) in as few as two months, the Department of Veterans Affairs (VA) now includes in its contract with Echosens the FibroScan® 430 mini+ portable technology.

Read More